<b>Targeted Inhibition of Tumor-Intrinsic SIRPα Improve anti-PD-1 Resistance by Enhancing T Cell Immunity and Inhibits</b><b> Tumor </b><b>Proliferation in Esophageal Cancer: Thera... by Xi-Yang Tang (13184496)

Supplementary Table 1 from Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors by Sarah E. Fenton (15062814)

Multistimuli-Responsive Porous Organic Polymers for Drug-Gas Anticancer Combination Therapy by Tina Skorjanc (4230178)

Subjects:

Model parameters. by Kanyarat Jitmana (18693060)

Subjects:

Correlation of parameters. by Kanyarat Jitmana (18693060)

Subjects:

Cox proportional hazards regression. by Kanyarat Jitmana (18693060)

Subjects:

Figure S9 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G₁–S Cell-Cycle Transition by Jingwei Zhang (288128)

Figure S10 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G₁–S Cell-Cycle Transition by Jingwei Zhang (288128)

Figure 1 from Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study by Clinton Yam (18716936)

SRC-3 treatment decreased tumor growth in a Jeko-1 ibrutinib resistant mouse model. by Imani Bijou (18275174)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

Syndecan ectodomain fragments decrease endothelial resistance via rho kinase. by Melanie Jannaway (6703577)

Supplementary Table 1 from Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair by Anna Solta (17387538)

Figure S4 from ER⁺ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors by Angel L. Guerrero-Zotano (7063892)

DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf by Bo Li (112195)

“…However, the rapid emergence of resistance toward doxorubicin threatens its clinical application, thus the need for combination therapy. …”

DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf by Bo Li (112195)

“…However, the rapid emergence of resistance toward doxorubicin threatens its clinical application, thus the need for combination therapy. …”

DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf by Bo Li (112195)

“…However, the rapid emergence of resistance toward doxorubicin threatens its clinical application, thus the need for combination therapy. …”

The novel fosfomycin resistance gene fosY is present on a genomic island in CC1 methicillin-resistant <i>Staphylococcus aureus</i> by Yiyi Chen (3075699)

“…<p>Fosfomycin has gained attention as a combination therapy for methicillin-resistant <i>Staphylococcus aureus</i> infections. …”

DataSheet_1_Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma.docx by Yan Zhuang (115199)

“…</p>Results<p>Our findings revealed a consistent decrease in the levels of complement components in the pomalidomide-resistant group. …”

Presentation_1_Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant Acinetobacter... by Mei-Ling Han (1612951)

“…<p>Background: Polymyxins are a last-line class of antibiotics against multidrug-resistant Acinetobacter baumannii. However, polymyxin resistance can emerge with monotherapy, highlighting the need for synergistic combination therapies. …”